30 January 2018 | News
The competition gathered more than 500 participants from leading research institutions and universities
Ardigen, a leading Polish company in bioinformatics & AI for precision medicine, proves its excellence in AI by winning the 2nd place in the prestigious NCI-CPTAC DREAM-Proteogenomics Challenge.
The competition gathered more than 500 participants from leading research institutions and universities including Stanford and Harvard. Ardigen joins forces with other top performing teams to further improve understanding of cancerogenesis.
The key components of the Challenge are the novel proteogenomic data measured by the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
In order to draw meaningful conclusions from such a complex dataset one needs to combine knowledge in molecular biology with that in statistical learning.
Ardigen AI Labs supports bioinformatics projects in providing state of the art AI and data science solutions.
Close collaboration of data scientists with experts in cancer biology, immunology, microbiome, or central nervous system gives the synergy effect and results in competitive edge.